1. Home
  2. ZLAB vs AXGN Comparison

ZLAB vs AXGN Comparison

Compare ZLAB & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

SELL

Current Price

$22.66

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo Axogen Inc.

AXGN

Axogen Inc.

SELL

Current Price

$48.78

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ZLAB
AXGN
Founded
2013
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
ZLAB
AXGN
Price
$22.66
$48.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
11
Target Price
$33.48
★ $59.09
AVG Volume (30 Days)
955.0K
★ 1.8M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.46
N/A
EPS
★ N/A
N/A
Revenue
★ $460,156,000.00
$225,208,000.00
Revenue This Year
N/A
$28.93
Revenue Next Year
$26.74
$28.26
P/E Ratio
★ N/A
N/A
Revenue Growth
15.33
★ 20.21
52 Week Low
$15.96
$23.00
52 Week High
$27.50
$52.91

Technical Indicators

Market Signals
Indicator
ZLAB
AXGN
Relative Strength Index (RSI) 45.61 75.68
Support Level $21.86 $38.75
Resistance Level $26.64 $52.91
Average True Range (ATR) 1.14 1.97
MACD -0.12 1.83
Stochastic Oscillator 33.86 91.87

Price Performance

Historical Comparison
ZLAB
AXGN

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: